Compounds > fluorouracil

fluorouracil and atracurium

fluorouracil has been researched along with atracurium in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	3 (42.86)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Farokhnia, F; Fazli, M; Khan, ZH; Maghsoudloo, M; Makarem, J; Zanjani, AP	1
Lu, Z; Wen, Q; Yabasin, IB; Yu, JC	1
Liu, Y; Wu, Y; Yuan, J; Zhou, Q	1

Reviews

1 review(s) available for fluorouracil and atracurium

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

6 other study(ies) available for fluorouracil and atracurium

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Chemotherapy alters cisatracurium induced neuromuscular blockade characteristics: A prospective cohort study. Journal of clinical anesthesia, 2017, Volume: 36 Topics: Adult; Anesthesia, General; Antineoplastic Combined Chemotherapy Protocols; Atracurium; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Mastectomy; Middle Aged; Monitoring, Intraoperative; Neoadjuvant Therapy; Neuromuscular Blockade; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Prospective Studies	2017
Cisatracurium-induced proliferation impairment and death of colorectal cancer cells, HCT116 is mediated by p53 dependent intrinsic apoptotic pathway in vitro. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 91 Topics: Apoptosis; Atracurium; Cell Cycle Checkpoints; Cell Proliferation; Colorectal Neoplasms; Fluorouracil; HCT116 Cells; Humans; Signal Transduction; Tumor Stem Cell Assay; Tumor Suppressor Protein p53	2017
Cisatracurium besilate enhances the TRAIL-induced apoptosis of gastric cancer cells via p53 signaling. Bioengineered, 2021, Volume: 12, Issue:2 Topics: Apoptosis; Atracurium; Cell Line, Tumor; Cell Proliferation; Fluorouracil; Humans; Signal Transduction; Stomach Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53	2021